In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin.

MLA

Le, Cheng-Foh, et al. “In Vivo Efficacy and Molecular Docking of Designed Peptide That Exhibits Potent Antipneumococcal Activity and Synergises in Combination with Penicillin.” Scientific Reports, vol. 5, July 2015, p. 11886. EBSCOhost, https://doi.org/10.1038/srep11886.

APA

Le, C.-F., Yusof, M. Y. M., Hassan, M. A. A., Lee, V. S., Isa, D. M., & Sekaran, S. D. (2015). In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin. Scientific Reports, 5, 11886. https://doi.org/10.1038/srep11886

Chicago

Le, Cheng-Foh, Mohd Yasim Mohd Yusof, Mahmood Ameen Abdulla Hassan, Vannajan Sanghiran Lee, Diyana Mohd Isa, and Shamala Devi Sekaran. 2015. “In Vivo Efficacy and Molecular Docking of Designed Peptide That Exhibits Potent Antipneumococcal Activity and Synergises in Combination with Penicillin.” Scientific Reports 5 (July): 11886. doi:10.1038/srep11886.